CapSure VDD-2 Lead (5038L, 5038S), CapSure VDD-2 Lead (5038), Service Kit-Pacemaker Repair Kit (5873C)
Medtronic, Inc. · Decision date Apr 15, 2026
What did the FDA decide?
FDA records P890003/S486 as a supplement to PMA P890003, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 15, 2026.
FDA approval order statement
to reduce the bioburden monitoring frequency from bi-weekly to monthly
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Apr 15, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P890003/S486
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- NVZ
- Decision code
- OK30
- Decision date
- Apr 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pulse generator, permanent, implantable.
- Applicant
- Medtronic, Inc.
- Product code
- NVZ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P890003/S482 · Related supplement
CareLink SmartSync Device Manager Base
P890003/S481 · Related supplement
SYNERGYST II PULSE GENERATOR MODELS 7070 & 7071
P890003/S483 · Related supplement
CareLink SmartSync Device Manager Base 24970A
P890003/S484 · Related supplement
CapSure VDD-2 Lead 5038, 5038L, 5038S Service Kit-Pacemaker Repair Kit 5873C Vitatron Brilliant S+ VDD Lead IMW14Q, IMW1
P890003/S486 received
Application receipt date recorded by FDA.
P890003/S486 · FDA decision
30-Day Notice
P890003/S485 · Related supplement
CareLink SmartSync Platform Application (M01A01); CareLink SmartSync Common Application (M01A02); CareLink SmartSync Hos
P890003/S487 · Related supplement
CareLink SmartSync Device Manager Base (24970A)
Timeline entries are records held by MedtechLedger for P890003. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P890003
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CareLink SmartSync Device Manager BaseP890003/S482 | Medtronic, Inc. | PMA supplement | Aug 12, 2025 | FDA |
SYNERGYST II PULSE GENERATOR MODELS 7070 & 7071P890003/S481 | Medtronic, Inc. | PMA supplement | Oct 30, 2025 | FDA |
CareLink SmartSync Device Manager Base 24970AP890003/S483 | Medtronic, Inc. | PMA supplement | Dec 3, 2025 | FDA |
| Medtronic, Inc. | PMA supplement | Feb 10, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | May 6, 2026 | FDA | |
CareLink SmartSync Device Manager Base (24970A)P890003/S487 | Medtronic, Inc. | PMA supplement | Jul 31, 2026 | FDA |
Explore the linked device profile
Other records with product code NVZ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 23, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 5, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Jul 31, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Jul 31, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P890003/S486
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





